Pharma Integrates 2022 Track 2
How can we use technology to improve health outcomes, improve sustainability and create robust supply chains?
Welcome and opening remarks
Formulating the future
There is a pressure to speed up time to market, but what can drug development scientists do to speed up this important stage?
Maureen Wedderburn | Non Executive Chair | Medicines Manufacturing Innovation Centre
Claire Thompson | Chief Executive Officer | Agility Life Sciences
Christopher Morton | Chief Executive Officer | ELEM Biotech
David O’Connell | Director of Scientific Affairs | PCI Pharma Services
Dolly Jacob | Director, Integrated Development Services, Early Development | Quotient Sciences
Anke Domdey | Director Pharmaceutical Development | Nanoform
The UK has committed to reduce its greenhouse-gas emissions to net zero by 2050. What is the Industry doing to support this?
Christophe Le Ret | Global Marketing Director | Umicore
Mark Cassidy | CEO & President | Ajinomoto Bio-Pharma Services Europe
Christian Jones | Chief Commercial Officer | Nanoform
Robert Williams | Procurement Director | AstraZeneca
Roland Brown | Director, Analytical R&D | Pfizer
Jack Eastwood | Chief Operating Officer | Protium
Detect. Inspect. HealthTech.
Innovations around Covid-19 changed the MedTech landscape, but are those learnings being adopted for other conditions? How are drug devices converging with digital?
Phil Carvil | HealthTec Cluster Manager | UKRI Science and Technology Facilities Council
Charlotte Lee-Sinclair | Principal consultant and founder | Third Culture Ventures
John Drakenberg | Co-founder & CEO | Alex Therapeutics
Rahul Kapoor | Director of Health Tech | CPI
Neil Tween | Chief Financial Officer | Owlstone Medical
Signed Sealed Delivered
How is technology enabling an efficient and robust supply chain?
Consumers, treatments and health systems are changing – can truly disruptive innovation in healthcare supply chains meet these needs?
How do corporates and start-ups collaborate to effect that change at pace?
Artificial Intelligence – hype, hope or happening?
AI is being applied to drug discovery, development, diagnosis and supply chains. How successful has it been so far? What does the future hold?
Ele Harwich | Director | Newmarket Strategy
Raminderpal Singh | Chief Executive Officer and co-Founder | Incubate.bio Ltd
Beth Fordham | Operations Director | White Swan
Ajay Mistry | Co-Founder & Chief Executive Officer, | Oppilotech
Steve Gardner | Chief Executive Officer | PrecisionLife Ltd
Jessica Morley | Director of Policy | Bennett Institute for Applied Data Science, University of Oxford